Used in pharmaceutical research as a key intermediate for developing kinase inhibitors, particularly in oncology. Shows potential in targeting signaling pathways involved in tumor growth and inflammation. Its structure supports high binding affinity to specific enzyme active sites, making it valuable in designing selective therapeutic agents. Also explored for use in neurodegenerative disease studies due to its ability to cross the blood-brain barrier. Commonly applied in structure-activity relationship (SAR) studies to optimize drug candidates for improved efficacy and safety.